Live biotherapeutic/Microbiome Based Therapeutics Market Size, Share & Trends Analysis Report By Product (VOWST (SER-109), REBYOTA, Visbiome, Other Pipeline Products), By Route of Administration (Oral Therapeutics, Rectal Therapeutics), By Target Disease Indication (Recurrent C. Difficile Infection, Dietary Management of Microbial Imbalance, Other Indications), By Distribution Channel, By End User, By Region, And Segment Forecasts, 2025-2034